Clinical Trials Using Aprepitant
Clinical trials are research studies that involve people. The clinical trials on this list are studying Aprepitant. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Ondansetron with or without Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Gliomas
This randomized phase II clinical trial studies the side effects and how well ondansetron given with or without aprepitant works in preventing chemotherapy-induced nausea and vomiting in patients with gliomas. Antiemetic drugs, such as ondansetron and aprepitant, may help lessen or prevent nausea and vomiting in patients treated with chemotherapy.
Location: Duke University Medical Center, Durham, North Carolina
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
This clinical trial is studying how well granisetron, aprepitant, and dexamethasone work in preventing nausea and vomiting in patients receiving chemotherapy for stage II, stage III, or stage IV ovarian cancer. Granisetron patch, aprepitant and dexamethasone may help lessen or prevent nausea and vomiting in patients receiving chemotherapy for stage II, stage III, or stage IV ovarian cancer.
Location: See Clinical Trials.gov